The Zotide Pen Device is used to administer teriparatide for the treatment of:

• Osteoporosis in postmenopausal women at high risk for fractures.
• Primary or hypogonadal osteoporosis in men at high risk for fractures.
• Glucocorticoid-induced osteoporosis in men and women at high risk for fractures.

Teriparatide, administered using the Zotide Pen Device, mimics the activity of the natural parathyroid hormone in the body. It stimulates the activity of osteoblasts, the cells responsible for bone formation. This leads to increased bone mineral density and strength, reducing the risk of fractures associated with osteoporosis. Regular administration as prescribed can help in the effective management of osteoporosis.

While the Zotide Pen Device itself does not interact with other medications, the teriparatide administered through it can have interactions. It's crucial to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Some interactions to be aware of include:

• Digoxin: Concurrent use may increase the risk of digitalis toxicity.
• Loop diuretics: May enhance the risk of hypercalcemia.
• Glucocorticoids: Long-term use may counteract the bone-forming effects of teriparatide.

Always consult with your healthcare provider before starting or stopping any medication while using teriparatide.

• Store the Zotide Pen Device at room temperature, away from direct sunlight and moisture.
• Do not freeze the device or expose it to extreme temperatures.
• Keep the device out of reach of children and pets. 
• Use a new needle for each injection to maintain hygiene and prevent infections. 
• Use ONLY zotide injections with this device.
• Dispose of used needles safely in a sharps container.

To use the Zotide Pen Device:

• Wash your hands thoroughly.
• Attach a new needle to the pen.
• Insert the Zotide cartridge containing teriparatide into the pen.
• Set the prescribed dose as directed by your healthcare provider.
• Clean the injection site (thigh or abdomen) with an alcohol swab.
• Inject the medication subcutaneously as instructed.
• Remove and dispose of the needle safely after each use.

Always follow the instructions provided by your healthcare provider or the device manual for proper usage.

Common Side Effects:

• Injection site reactions (pain, redness, swelling)
• Nausea
• Leg cramps
• Dizziness

Serious Side Effects:

• Hypercalcemia (elevated calcium levels)
• Allergic reactions (rash, itching, swelling)
• Osteosarcoma (a rare type of bone cancer)

If you experience any severe side effects, discontinue use and consult your healthcare provider immediately.

Before starting therapy with teriparatide using the Zotide Pen Device, ensure you understand the correct usage technique. Regularly monitor your calcium levels as advised by your doctor. Maintain a healthy lifestyle with adequate calcium and vitamin D intake to support bone health. Report any unusual symptoms or side effects to your healthcare provider promptly.

1. KD Tripathi, Hormones and Drugs Affecting Calcium Balance, Essentials of Medical Pharmacology, 8th Edition, 2019, 360-372
2. https://www.ciplamed.com/product-index/ZOTIDE-Injection